To study antibody responses against SARS-CoV-2 nucleoprotein, we analyzed serum IgG, IgA, and IgM antibody responses in 119 serum samples collected from 101 PCR-confirmed COVID-19 patients. This evidence concerns the gene CD79A and COVID-19.